DOC-1230MSG emailChapter GLD
Needs review
medication_double-check_v4.msg
Owner: Dr. Sarah Jenkins
Uploaded: 11 Aug 2026
Version: v3
Size: 703.9 MB
0%Quality
Quality Assessment
This document is missing an explicit revision cadence or committee approval stamp, which a surveyor will typically ask for.
Classification:medication double-check
Effective year:2025
Review due:Q2 2027
What this document proves
Measurable element alignments and explainability trace
GLD.2Critical Gap (GAP-1230)
Governance, leadership, direction — control 2: documented process, responsible owner and evidence of practice (paraphrased)
GLD.2
medication_double-check_v4.msg
Documented Policy Evidence
Verification Gap Detected
GLD.3Verified · Requirement Met
Governance, leadership, direction — control 3: documented process, responsible owner and evidence of practice (paraphrased)
GLD.3
medication_double-check_v4.msg
Documented Policy Evidence
High Confidence (88%)
GLD.4Verified · Requirement Met
Governance, leadership, direction — control 4: documented process, responsible owner and evidence of practice (paraphrased)
GLD.4
medication_double-check_v4.msg
Documented Policy Evidence
High Confidence (88%)
critical
GAP-1230Open
Documentation gap in medication_double-check_v4.msg: Policy requires verified committee endorsement and alignment with JCI GLD Measurable Elements.
Target requirement: GLD.2